The involvement of platelets in diverse physiological processes as well as in hypersensitivity and inflammatory reactions is mediated by structurally distinct platelet activating factors. Of these, one of the most potent is the phospholipid 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine (AGEPC). AGEPC activates platelets by binding to specific, high-affinity receptors and recently, a 180,000 dalton platelet membrane protein which binds AGEPC was purified to homogeneity by ligand specific affinity chromatography. The goal of the proposed research program is to delineate the subcellular mechanisms by which AGEPC contributes to immunological reactions by exploring in detail the interaction of AGEPC with its specific receptor and by delineating the biochemical consequences of this interatin which mediate platelet activation. The relationship between the binding protein and the AGEPC receptor will be determined by producing antisera to the binding protein and monoclonal antibodies which specifically modulate AGEPC binding. New methods for quantitating AGEPC binding by the solubilized receptor and the purified binding protein will be developed in order to analyze in depth their binding constants and affinities. If these antigenic and functional studies indicate that the binding protein is not the AGEPC receptor then monoclonal antibodies to the receptor will be utilized to isolate the receptor for a detailed analysis of its functional properties. Specific antibody will be used also to define the location of the receptor in platelets, to track the receptor during platelet activation, to compare the receptor to other platelet membrane proteins and to compare the receptor in platelets and other cell types. While the new methods and antibodies are being developed the mechanisms of activating signal transduction will be examined by analyzing the initiation of protein kinase and phospholipase activity in platelet membranes and solubilized receptor systems. The information derived from these binding and functional studies of the receptor in unpurified systems will then be utilized to guide studies which characterize the functional properties of the isolated, purified receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI022141-03
Application #
3132878
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1985-12-01
Project End
1988-11-30
Budget Start
1987-12-01
Budget End
1988-11-30
Support Year
3
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Rosenbaum, J T; Boney, R S; Samples, J R et al. (1991) Synthesis of platelet activating factor by ocular tissue from inflamed eyes. Arch Ophthalmol 109:410-3
Valone, F H (1991) Synthesis of platelet-activating factor by human monocytes stimulated by platelet-activating factor. J Allergy Clin Immunol 87:715-20
Ruis, N M; Rose, J K; Valone, F H (1991) Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. Lipids 26:1060-4
Barthelson, R A; Valone, F H (1991) Platelet-activating factor stimulates expression of IL-1 beta mRNA in THP-1 cells. Lipids 26:257-60
Barthelson, R A; Potter, T; Valone, F H (1990) Synergistic increases in IL-1 synthesis by the human monocytic cell line THP-1 treated with PAF and endotoxin. Cell Immunol 125:142-50
Barthelson, R; Valone, F (1990) Interaction of platelet-activating factor with interferon-gamma in the stimulation of interleukin-1 production by human monocytes. J Allergy Clin Immunol 86:193-201
Sullam, P M; Payan, D G; Dazin, P F et al. (1990) Binding of viridans group streptococci to human platelets: a quantitative analysis. Infect Immun 58:3802-6
Rose, J K; Debs, R A; Philip, R et al. (1990) Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholine. J Immunol 144:3513-7
Valone, F H; Barthelson, R; Ruis, N M (1989) Mechanisms for biphasic or persistent immunologic reactions induced by platelet-activating factor. Prog Clin Biol Res 297:71-80;discussion 80-1
Shalit, M; Valone, F H; Atkins, P C et al. (1989) Late appearance of phospholipid platelet-activating factor and leukotriene B4 in human skin after repeated antigen challenge. J Allergy Clin Immunol 83:691-6

Showing the most recent 10 out of 22 publications